4.3 Article

Primary tumor- and metastasis-derived colon cancer cells differently modulate connexin expression and function in human capillary endothelial cells

期刊

ONCOTARGET
卷 6, 期 30, 页码 28800-28815

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.4894

关键词

GJIC; Cx32; Cx43; HSP27; CXCR2

资金

  1. Centre National de la Recherche Scientifique (CNRS)
  2. Institut National de la Sante et de la Recherche Medicale (INSERM)
  3. Ligue Nationale Contre le Cancer
  4. Agence Nationale de la Recherche
  5. Institut National du Cancer (INCa)

向作者/读者索取更多资源

A gradual loss of functional gap junction between tumor cells has been reported with colorectal cancer (CRC) progression. Here, we explored if colon cancer cells could also affect gap junctions in blood capillary cells. Human microvascular endothelial cells (HMEC) were cultured with two CRC cell lines established from a unique patient. SW480 cells, derived from the primary tumor, migrate much faster across HMEC monolayer than SW620 cells derived from a metastatic site. The motile SW480 cells highly express and release HSP27 that increases gap junction formation with HMEC. Soluble HSP27 phosphorylates the connexin Cx43 on serine residues and induces its interaction with the oncoprotein 14-3-3, which promotes Cx43 delivery at the plasma membrane. The factors secreted by less motile SW620 cells do not affect Cx43 expression but up-regulate the expression of the connexin Cx32 through an activation of the chemokine receptor CXCR2. In turn, SW620 secreted factors induce tubulogenesis and ATP release. Altogether, cell lines derived from CRC primary tumor and metastasis differentially adapt endothelial cell functions by modulating connexin expression through released mediators.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Clinical Neurology

Editorial: COVID-19 in CNS and PNS: Basic and Clinical Focus on the Mechanisms of Infection and New Tools for the Therapeutic Approach

Jorge Matias-Guiu, Jordi A. Matias-Guiu, Carmen Garrido, Genaro Pimienta, Patricio F. Reyes, Abdul Mannan Baig, Ulises Gomez-Pinedo

FRONTIERS IN NEUROLOGY (2022)

Article Medicine, General & Internal

Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients

Nicolas Chapuis, Nusaibah Ibrahimi, Thibaut Belmondo, Claire Goulvestre, Anne-Emmanuelle Berger, Alice-Andree Mariaggi, Muriel Andrieu, Camille Chenevier-Gobeaux, Arnaud Bayle, Lydia Campos, Cherifa Cheurfa, Richard Chocron, Jean-Luc Diehl, Benoit Doumenc, Jerome Duchemin, Manon Duprat, Fabien Francois, Nicolas Gendron, Tristant Mirault, Frederic Pene, Aurelien Philippe, Fanny Pommeret, Olivier Sanchez, David M. Smadja, Tali-Anne Szwebel, Aymeric Silvin, Florent Ginhoux, Ludovic Lacroix, Gerome Jules-Clement, Sarobidy Rapeteramana, Colette Mavier, Laura Steller, Barbara Perniconi, Fabrice Andre, Damien Drubay, Michaela Fontenay, Sophie Hue, Stephane Paul, Eric Solary

Summary: Serial monitoring of calprotectin levels in moderate COVID-19 patients can predict the risk of poor outcomes. An online software algorithm has been designed to monitor the risk probability in individual patients.

EBIOMEDICINE (2022)

Article Cell Biology

Leptin-Induced HLA-G Inhibits Myometrial Contraction and Differentiation

Maeva Wendremaire, Tatiana E. Lopez, Marina Barrichon, Hang Zhang, Tarik Hadi, Xiang-Yang Ye, Fabrice Neiers, Marc Bardou, Paul Sagot, Carmen Garrido, Frederic Lirussi

Summary: This study evaluated the effects of leptin on myometrial contraction and differentiation using a co-culture model of human primary macrophages and myocytes. The results showed that leptin had different effects on myocytes and macrophages depending on the dose, and a low concentration of leptin inhibits myocyte contraction, differentiation, and macrophage-induced reactive oxygen species (ROS) production. Leptin also increased the expression of HLA-G, suggesting its tocolytic effect may be driven by HLA-G.
Article Oncology

The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes

Tamara K. Moyo, Jason H. Mendler, Raphael Itzykson, Ashwin Kishtagari, Eric Solary, Adam C. Seegmiller, Aaron T. Gerds, Gregory D. Ayers, Amy E. Dezern, Aziz Nazha, Peter Valent, Arjan A. van de Loosdrecht, Francesco Onida, Lisa Pleyer, Blanca Xicoy Cirici, Raoul Tibes, Klaus Geissler, Rami S. Komrokji, Jing Zhang, Ulrich Germing, David P. Steensma, Daniel H. Wiseman, Michael Pfeilstoeecker, Chiara Elena, Nicholas C. P. Cross, Michael Luebbert, Ruben A. Mesa, Guillermo F. Sanz, Uwe Platzbecker, Mrinal M. Patnaik, Eric Padron, Valeria Santini, Pierre Fenaux, Michael R. Savona, Jean-Jacques Kiladjian, Guillermo Montalban-Bravo

Summary: Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are rare hematologic malignancies that have a significant impact on patient quality of life. Current treatment options have poor outcomes, making it a critical area of unmet clinical need. The ABNL-MARRO project aims to advance the treatment of MDS/MPN and explore clinical and pathologic markers of disease severity, prognosis, and treatment response.

BMC CANCER (2022)

Article Biochemistry & Molecular Biology

cIAP1/TRAF2 interplay promotes tumor growth through the activation of STAT3

Baptiste Dumetier, Aymeric Zadoroznyj, Jean Berthelet, Sebastien Causse, Jennifer Allegre, Pauline Bourgeois, Florine Cattin, Cindy Racoeur, Catherine Paul, Carmen Garrido, Laurence Dubrez

Summary: Cellular inhibitor of apoptosis-1 (cIAP1) is a signaling regulator involved in the regulation of multiple signaling pathways and has oncogenic properties. It interacts with the molecular adaptor TRAF2 to form signaling complexes and promotes tumor growth through the activation of the JAK/STAT3 pathway.

ONCOGENE (2023)

Review Oncology

Heat-Shock Proteins in Leukemia and Lymphoma: Multitargets for Innovative Therapeutic Approaches

Vincent Cabaud-Gibouin, Manon Durand, Ronan Quere, Francois Girodon, Carmen Garrido, Gaetan Jego

Summary: Heat-shock proteins (HSPs) are molecular chaperones that are overexpressed in tumor cells and play a crucial role in their survival. In leukemia and lymphoma, HSPs have been found to have distinctive cytoprotective effects on various cell death and growth pathways. This review examines the implications of HSPs in these pathways in hematological malignancies and discusses the importance of detecting and targeting them for future innovative treatment strategies.

CANCERS (2023)

Article Chemistry, Medicinal

HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling

Julie Tanguy, Pierre-Marie Boutanquoi, Olivier Burgy, Lucile Dondaine, Guillaume Beltramo, Burhan Uyanik, Carmen Garrido, Philippe Bonniaud, Pierre-Simon Bellaye, Francoise Goirand

Summary: In this study, we discovered that inhibiting HSPB5 with NCI-41356 could limit pulmonary fibrosis by reducing the accumulation of collagen and pro-fibrotic markers. This effect is likely mediated through the inhibition of HSPB5/SMAD4 interaction and modulation of SMAD4 and TGF-beta 1 signaling. Further investigations are needed to determine the translatability of these results to humans.

PHARMACEUTICALS (2023)

Review Biochemistry & Molecular Biology

Apoptotic cell death in disease-Current understanding of the NCCD 2023

Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A. Aaronson, John M. Abrams, Dieter Adam, Massimiliano Agostini, Patrizia Agostinis, Emad S. Alnemri, Lucia Altucci, Ivano Amelio, David W. Andrews, Rami Aqeilan, Eli Arama, Eric H. Baehrecke, Siddharth Balachandran, Daniele Bano, Nickolai A. Barlev, Jiri Bartek, Nicolas G. Bazan, Christoph Becker, Francesca Bernassola, Mathieu J. M. Bertrand, Marco E. Bianchi, Mikhail V. Blagosklonny, J. Magarian Blander, Giovanni Blandino, Klas Blomgren, Christoph Borner, Carl D. Bortner, Pierluigi Bove, Patricia Boya, Catherine Brenner, Petr Broz, Thomas Brunner, Rune Busk Damgaard, George A. Calin, Michelangelo Campanella, Eleonora Candi, Michele Carbone, Didac Carmona-Gutierrez, Francesco Cecconi, Francis K-M Chan, Guo-Qiang Chen, Quan Chen, Youhai H. Chen, Emily H. Cheng, Jerry E. Chipuk, John A. Cidlowski, Aaron Ciechanover, Gennaro Ciliberto, Marcus Conrad, Juan R. Cubillos-Ruiz, Peter E. Czabotar, Vincenzo D'Angiolella, Mads Daugaard, Ted M. Dawson, Valina L. Dawson, Ruggero De Maria, Bart De Strooper, Klaus-Michael Debatin, Ralph J. Deberardinis, Alexei Degterev, Giannino Del Sal, Mohanish Deshmukh, Francesco Di Virgilio, Marc Diederich, Scott J. Dixon, Brian D. Dynlacht, Wafik S. El-Deiry, John W. Elrod, Kurt Engeland, Gian Maria Fimia, Claudia Galassi, Carlo Ganini, Ana J. Garcia-Saez, Abhishek D. Garg, Carmen Garrido, Evripidis Gavathiotis, Motti Gerlic, Sourav Ghosh, Douglas R. Green, Lloyd A. Greene, Hinrich Gronemeyer, Georg Haecker, Gyorgy Hajnoczky, J. Marie Hardwick, Ygal Haupt, Sudan He, David M. Heery, Michael O. Hengartner, Claudio Hetz, David A. Hildeman, Hidenori Ichijo, Satoshi Inoue, Marja Jaeaettelae, Ana Janic, Bertrand Joseph, Philipp J. Jost, Thirumala-Devi Kanneganti, Michael Karin, Hamid Kashkar, Thomas Kaufmann, Gemma L. Kelly, Oliver Kepp, Adi Kimchi, Richard N. Kitsis, Daniel J. Klionsky, Ruth Kluck, Dmitri Krysko, Dagmar Kulms, Sharad Kumar, Sergio Lavandero, Inna N. Lavrik, John J. Lemasters, Gianmaria Liccardi, Andreas Linkermann, Stuart A. Lipton, Richard A. Lockshin, Carlos Lopez-Otin, Tom Luedde, Marion MacFarlane, Frank Madeo, Walter Malorni, Gwenola Manic, Roberto Mantovani, Saverio Marchi, Jean-Christophe Marine, Seamus J. Martin, Jean-Claude Martinou, Pier G. Mastroberardino, Jan Paul Medema, Patrick Mehlen, Pascal Meier, Gerry Melino, Sonia Melino, Edward A. Miao, Ute M. Moll, Cristina Munoz-Pinedo, Daniel J. Murphy, Maria Victoria Niklison-Chirou, Flavia Novelli, Gabriel Nunez, Andrew Oberst, Dimitry Ofengeim, Joseph T. Opferman, Moshe Oren, Michele Pagano, Theocharis Panaretakis, Manolis Pasparakis, Josef M. Penninger, Francesca Pentimalli, David M. Pereira, Shazib Pervaiz, Marcus E. Peter, Paolo Pinton, Giovanni Porta, Jochen H. M. Prehn, Hamsa Puthalakath, Gabriel A. Rabinovich, Krishnaraj Rajalingam, Kodi S. Ravichandran, Markus Rehm, Jean-Ehrland Ricci, Rosario Rizzuto, Nirmal Robinson, Cecilia M. P. Rodrigues, Barak Rotblat, Carla Rothlin, David C. Rubinsztein, Thomas Rudel, Alessandro Rufini, Kevin M. Ryan, Kristopher A. Sarosiek, Akira Sawa, Emre Sayan, Kate Schroder, Luca Scorrano, Federico Sesti, Feng Shao, Yufang Shi, Giuseppe S. Sica, John Silke, Hans-Uwe Simon, Antonella Sistigu, Anastasis Stephanou, Brent R. Stockwell, Flavie Strapazzon, Andreas Strasser, Liming Sun, Erwei Sun, Qiang Sun, Gyorgy Szabadkai, Stephen W. G. Tait, Daolin Tang, Nektarios Tavernarakis, Carol M. Troy, Boris Turk, Nicoletta Urbano, Peter Vandenabeele, Tom Vanden Berghe, Matthew G. Vander Heiden, Jacqueline L. Vanderluit, Alexei Verkhratsky, Andreas Villunger, Silvia von Karstedt, Anne K. Voss, Karen H. Vousden, Domagoj Vucic, Daniela Vuri, Erwin F. Wagner, Henning Walczak, David Wallach, Ruoning Wang, Ying Wang, Achim Weber, Will Wood, Takahiro Yamazaki, Huang-Tian Yang, Zahra Zakeri, Joanna E. Zawacka-Pankau, Lin Zhang, Haibing Zhang, Boris Zhivotovsky, Wenzhao Zhou, Mauro Piacentini, Guido Kroemer, Lorenzo Galluzzi

Summary: Apoptosis is a regulated cell death process involving caspase family proteases. Inhibiting or delaying apoptosis experimentally through pharmacological and genetic strategies has demonstrated its importance in embryonic development, tissue homeostasis, and the pathogenesis of various human disorders. Defects in apoptotic cell death machinery impair development and promote oncogenesis, while inappropriate activation of apoptosis contributes to cell loss and tissue damage in neurological, cardiovascular, renal, hepatic, infectious, neoplastic, and inflammatory conditions.

CELL DEATH AND DIFFERENTIATION (2023)

Article Chemistry, Medicinal

Design, Synthesis and Biological Evaluation of Histone Deacetylase Inhibitors Based on Pyrrolo[2,3-d]pyrimidine and Pyrrolo[2,3-b]pyridine Scaffolds

Nian-Dong Mao, Yuan Gao, Xia-Wen Dang, Ji-Long Duan, Zi Hui, Hao Che, Yueying Xu, Hang Zhang, Xingrui He, Carmen Garrido, Xiang-Yang Ye

Summary: The study focuses on the design and synthesis of novel HDAC inhibitors based on pyrrolo[2,3-d]pyrimidine and pyrrolo[2,3-b]pyridine scaffolds. Compound B3 showed potent inhibitory activity against multiple HDACs and exhibited significant antiproliferative effects on three tumor cell lines. Mechanistic studies revealed that B3 induces cell cycle arrest and apoptosis in WSU-DLCL-2 cells. These findings suggest further investigation of the compound series for hematological malignancy treatment.

CHEMMEDCHEM (2023)

Article Biochemistry & Molecular Biology

Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged Tissues

Stephanie Solier, Michele Mondini, Lydia Meziani, Arnaud Jacquel, Catherine Lacout, Tom Vanden Berghe, Yvon Jule, Jean-Claude Martinou, Gerard Pierron, Julie Riviere, Marc Deloger, Corinne Dupuy, Anny Slama-Schwok, Nathalie Droin, Peter Vandenabeele, Patrick Auberger, Eric Deutsch, Jamel El-Benna, Pham My-Chan Dang, Eric Solary

Summary: Circulating monocytes are recruited to damaged tissues to generate macrophages that modulate disease progression. Activation of caspase-3 and caspase-7, located near mitochondria, is involved in the generation of monocyte-derived macrophages stimulated by Colony-stimulating factor-1 (CSF-1). A non-conventional pathway that involves caspases and activates NOX2 is responsible for CSF1-driven monocyte differentiation, and targeting this pathway may have therapeutic implications for modulating macrophage polarization in damaged tissues.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cell Biology

Bone marrow-derived extracellular vesicles carry the TGF-β signal transducer Smad2 to preserve hematopoietic stem cells in mice

Flavie Gautheron, Aleksandra Georgievski, Carmen Garrido, Ronan Quere

Summary: Extracellular vesicles (EVs) released by cells in the bone marrow (BM) play an important role in regulating hematopoietic stem cells (HSC) through the transport of bioactive phosphorylated Smad2 (p-Smad2). We found that the EV inhibitor Calpeptin significantly affected the production of p-Smad2-carrying EVs in mouse BM, leading to alterations in HSC quiescence and maintenance. Our study also revealed that p-Smad2 is necessary for the ex vivo maintenance of HSC, as EVs lacking p-Smad2 failed to support HSC survival.

CELL DEATH DISCOVERY (2023)

Article Cell Biology

p16High senescence restricts cellular plasticity during somatic cell reprogramming

Bogdan B. Grigorash, Dominic van Essen, Guixian Liang, Laurent Grosse, Alexander Emelyanov, Zhixin Kang, Alexey Korablev, Benoit Kanzler, Clement Molina, Elsa Lopez, Oleg N. Demidov, Carmen Garrido, Feng Liu, Simona Saccani, Dmitry V. Bulavin

Summary: Depletion of senescent cells can promote the reprogramming of somatic cells into totipotent-like stem cells and have positive effects on tissue rejuvenation.

NATURE CELL BIOLOGY (2023)

Correction Multidisciplinary Sciences

CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder (vol 13, 7002, 2022)

Aurelie de Thonel, Johanna K. Ahlskog, Kevin Daupin, Veronique Dubreuil, Jeremy Berthelet, Carole Chaput, Geoffrey Pires, Camille Leonetti, Ryma Abane, Lluis Cordon Barris, Isabelle Leray, Anna L. Aalto, Sarah Naceri, Marine Cordonnier, Carene Benasolo, Matthieu Sanial, Agathe Duchateau, Anniina Vihervaara, Mikael C. Puustinen, Federico Miozzo, Patricia Fergelot, Elise Lebigot, Alain Verloes, Pierre Gressens, Didier Lacombe, Jessica Gobbo, Carmen Garrido, Sandy D. Westerheide, Laurent David, Michel Petitjean, Olivier Taboureau, Fernando Rodrigues-Lima, Sandrine Passemard, Delara Saberan-Djoneidi, Laurent Nguyen, Madeline Lancaster, Lea Sistonen, Valerie Mezger

NATURE COMMUNICATIONS (2023)

Review Biochemistry & Molecular Biology

Recent progress in discovery of novel AAK1 inhibitors: from pain therapy to potential anti-viral agents

Ying-Hui Yuan, Nian-Dong Mao, Ji-Long Duan, Hang Zhang, Carmen Garrido, Frederic Lirussi, Yuan Gao, Tian Xie, Xiang-Yang Ye

Summary: This article discusses AAK1 inhibitors from the perspectives of structure-based rational molecular design, pharmacology, toxicology, and synthetic routes, aiming to provide up-to-date information and accelerate drug discovery programs in the field of AAK1 small molecule inhibitors.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)

Article Medicine, Research & Experimental

Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases

Vincent Jachiet, Laure Ricard, Pierre Hirsch, Florent Malard, Laurent Pascal, Odile Beyne-Rauzy, Pierre Peterlin, Alexandre Thibault Jacques Maria, Norbert Vey, Maud D'Aveni, Marie-Pierre Gourin, Sophie Dimicoli-Salazar, Anne Banos, Stefan Wickenhauser, Louis Terriou, Benoit De Renzis, Eric Durot, Shanti Natarajan-Ame, Anne Vekhoff, Laurent Voillat, Sophie Park, Julien Vinit, Celine Dieval, Azeddine Dellal, Vincent Grobost, Lise Willems, Julien Rossignol, Eric Solary, Olivier Kosmider, Nicolas Dulphy, Lin Pierre Zhao, Lionel Ades, Pierre Fenaux, Olivier Fain, Mohamad Mohty, Beatrice Gaugler, Arsene Mekinian

Summary: Background systemic inflammatory and autoimmune diseases (SIADs) occur in a significant proportion of myelodysplastic syndrome (MDS) patients. The recently identified VEXAS syndrome, associated with somatic mutations in UBA1, is characterized by severe inflammatory conditions and hematological abnormalities, including MDS. However, the mechanisms underlying the association between MDS and SIADs are largely unknown. This study aimed to evaluate myeloid immune cell subsets in MDS patients with and without SIAD and compare them to healthy controls.

CLINICAL AND EXPERIMENTAL MEDICINE (2023)

暂无数据